Market research
002880.SHE Shenzhen Weiguang Biological Products Co., Ltd
SHE CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 5B
- P/E ratio
- 26.95
- Analyst target
- 32
- Dividend yield
- 0.8%
- Beta
- 0.29
Community
Investor discussion
1 comment
Sign in to join the 002880.SHE discussion.
5 years, 5 months ago
Shenzhen Weiguang Biological Products Co., Ltd is currently in a long term downtrend where the price is trading 19.8% below its 200 day moving average.
From a valuation standpoint, the stock is 8.0% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 10.4.
Shenzhen Weiguang Biological Products Co., Ltd's total revenue rose by 15.3% to $200M since the same quarter in the previous year.
Its net income has increased by 11.8% to $43M since the same quarter in the previous year.
Finally, its free cash flow fell by 188.9% to $-47M since the same quarter in the previous year.
Based on the above factors, Shenzhen Weiguang Biological Products Co., Ltd gets an overall score of 2/5.